Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Pirbright reveals new insights into COVID-19
The origin of the COVID-19 outbreak remains unclear because no immediately related coronaviruses have been identified in animals.

Study indicates how the virus could have adapted from bats to humans. 

Researchers at The Pirbright Institute have revealed new insights into how the virus that causes COVID-19 could have adapted from bats to humans.

Their study, published in the journal PLOS Biology, identifies key differences in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could be responsible for the jump from bats to humans, as well as other animals it could infect.

Dr Dalan Bailey, head of the Viral Glycoproteins Group at Pirbright, said: “Uncovering the common traits that allow viruses to jump between animals and humans helps us to identify potential reservoirs of disease and forewarn us of future threats.

“Using molecular techniques to study coronavirus spike proteins in isolation, without ever needing to work with the SARS-CoV-2 virus, has enabled us to take an in-depth look at how genetic differences in coronavirus spike proteins and animal ACE2 receptors influence which animals the virus may be able to infect.”

Comparing genomes
The origin of the COVID-19 outbreak remains unclear because no immediately related coronaviruses have been identified in animals. The bat coronavirus, RaTG13, is the closet known relative, with a 96 per cent similarity to the SARS-CoV-2 genome.

In the study, researchers compared the genomes of both viruses, identifying several regions that differed between their spike proteins - those which the virus uses to bind to the ACE2 surface receptors of cells to gain entry.

Using a method that does not involve live virus, the scientists swapped these regions to examine how well the resulting spike proteins bound to human ACE2 receptors.

They found that SARS-CoV-2 spikes containing RaTG13 regions were unable to bind to human ACE2 receptors effectively. Conversely, the RaTG13 spikes containing SARS-CoV-2 regions could bind more efficiently to human receptors, although not to the same level as the unedited SARS-CoV-2 spike protein.

This finding could indicate that similar changes in the SARS-CoV-2 spike protein occurred historically, which may have played a key role in allowing the virus to jump the species barrier, the researchers said.

Future threats
The scientists also noted that these genetic adaptions were similar to those made by severe acute respiratory syndrome coronavirus (SARS-CoV) when it adapted from bats to infect humans, suggesting there may be a common mechanism by which this family of viruses mutates.

With this knowledge, researchers may in future be able to identify viruses circulating in animals that could adapt to infect humans and pose a pandemic threat.

Other animals
Finally, the team investigated whether the SARS-CoV-2 spike protein could bind to the ACE2 receptors of 22 different animals. They found that bat and bird receptors made the weakest interactions with SARS-CoV-2, giving weight to the evidence that SARS-CoV-2 likely adapted its spike protein when it jumped from bats into people.

Dogs, cats and cattle had the strongest interactors with the SARS-CoV-2 spike protein, suggesting that efficient entry into cells could mean that infection may establish easier in these animals.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.